Cite

HARVARD Citation

    Thomas, E. et al. (2016). IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice. Journal of ovarian research. 9 (1), pp. 1-11. [Online]. 
  
Back to record